These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 36702360)

  • 21. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The microbiome and inflammatory bowel disease.
    Glassner KL; Abraham BP; Quigley EMM
    J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative analyses of probiotics, pathogenic infections and host immune response highlight the importance of gut microbiota in understanding disease recovery in rainbow trout (Oncorhynchus mykiss).
    Rasmussen JA; Villumsen KR; von Gersdorff Jørgensen L; Forberg T; Zuo S; Kania PW; Buchmann K; Kristiansen K; Bojesen AM; Limborg MT
    J Appl Microbiol; 2022 Apr; 132(4):3201-3216. PubMed ID: 35032344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host immune interactions in chronic inflammatory gastrointestinal conditions.
    Caminero A; Pinto-Sanchez MI
    Curr Opin Gastroenterol; 2020 Nov; 36(6):479-484. PubMed ID: 32868507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Gut Microbiota of Laying Hens and Its Manipulation with Prebiotics and Probiotics To Enhance Gut Health and Food Safety.
    Khan S; Moore RJ; Stanley D; Chousalkar KK
    Appl Environ Microbiol; 2020 Jun; 86(13):. PubMed ID: 32332137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease.
    Kumar A; Al-Hassi HO; Steed H; Phipps O; Brookes MJ
    Can J Gastroenterol Hepatol; 2022; 2022():8416578. PubMed ID: 35360442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut dysbiosis and paediatric Crohn's disease.
    Brusaferro A; Cavalli E; Farinelli E; Cozzali R; Principi N; Esposito S
    J Infect; 2019 Jan; 78(1):1-7. PubMed ID: 30336176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.
    Ullah H; Tovchiga O; Daglia M; Khan H
    Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altering the gut microbiome to potentially modulate behavioral manifestations in autism spectrum disorders: A systematic review.
    Davies C; Mishra D; Eshraghi RS; Mittal J; Sinha R; Bulut E; Mittal R; Eshraghi AA
    Neurosci Biobehav Rev; 2021 Sep; 128():549-557. PubMed ID: 34271306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases.
    Oniszczuk A; Oniszczuk T; Gancarz M; Szymańska J
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33671813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease.
    Sitkin S; Pokrotnieks J
    Inflamm Bowel Dis; 2023 Nov; 29(11):e40-e41. PubMed ID: 37672357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.
    Hu Y; Chen Z; Xu C; Kan S; Chen D
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human gut microbiota/microbiome in health and diseases: a review.
    Gomaa EZ
    Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel polyphenolic prebiotic and probiotic formulation have synergistic effects on the gut microbiota influencing Drosophila melanogaster physiology.
    Westfall S; Lomis N; Prakash S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):441-455. PubMed ID: 29644870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.